Page last updated: 2024-09-05

enrasentan and enalapril

enrasentan has been researched along with enalapril in 1 studies

Compound Research Comparison

Studies
(enrasentan)
Trials
(enrasentan)
Recent Studies (post-2010)
(enrasentan)
Studies
(enalapril)
Trials
(enalapril)
Recent Studies (post-2010) (enalapril)
32206,3111,924859

Protein Interaction Comparison

ProteinTaxonomyenrasentan (IC50)enalapril (IC50)
Angiotensin-converting enzyme Homo sapiens (human)0.3536
Angiotensin-converting enzymeOryctolagus cuniculus (rabbit)2.7083
Type-2 angiotensin II receptorRattus norvegicus (Norway rat)1.2
Angiotensin-converting enzymeRattus norvegicus (Norway rat)0.14
Angiotensin-converting enzyme 2 Homo sapiens (human)0.14

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barlow, MM; Cleland, JG; Dargie, HJ; Groenning, BA; Grothues, F; Pennell, DJ; Prasad, SK; Smith, GC1

Trials

1 trial(s) available for enrasentan and enalapril

ArticleYear
Comparison of the dual receptor endothelin antagonist enrasentan with enalapril in asymptomatic left ventricular systolic dysfunction: a cardiovascular magnetic resonance study.
    Heart (British Cardiac Society), 2006, Volume: 92, Issue:6

    Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Carboxylic Acids; Disease Progression; Enalapril; Female; Heart Failure; Humans; Indans; Magnetic Resonance Angiography; Male; Middle Aged; Neurotransmitter Agents; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Remodeling

2006